Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Depreciation & Amortization (CF) (2020 - 2021)

Historic Depreciation & Amortization (CF) for Design Therapeutics (DSGN) over the last 2 years, with Q4 2021 value amounting to $82000.0.

  • Design Therapeutics' Depreciation & Amortization (CF) rose 195000.0% to $82000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $129000.0, marking a year-over-year increase of 312500.0%. This contributed to the annual value of $596000.0 for FY2024, which is 1098.7% up from last year.
  • As of Q4 2021, Design Therapeutics' Depreciation & Amortization (CF) stood at $82000.0, which was up 195000.0% from $31000.0 recorded in Q3 2021.
  • Design Therapeutics' Depreciation & Amortization (CF)'s 5-year high stood at $82000.0 during Q4 2021, with a 5-year trough of $4000.0 in Q4 2020.